A. Each pharmacy permittee shall implement or participate in a continuous quality assurance (CQA) program. A pharmacy permittee meets the requirements of this Section if it holds a current general, special or rural general hospital license from the Arizona Department of Health Services and is any of the following:
- 1. Certified by the Centers for Medicare and Medicaid Services to participate in the Medicare or Medicaid programs;
- 2. Accredited by the Joint Commission on the Accreditation of Healthcare Organizations; or
- 3. Accredited by the American Osteopathic Association.
B. A pharmacy permittee or the pharmacist-in-charge shall ensure that:
- 1. The pharmacy develops, implements, and utilizes a CQ program consistent with the requirements of this Section and A.R.S. § 32-1973;
- 2. The medication error data generated by the CQA program is utilized and reviewed on a regular basis, as required by subsection (D); and
- 3. Training records, policies and procedures, and other program records or documents, other than medication error data, are maintained for a minimum of two years in the pharmacy or in a readily retrievable manner.
C. A pharmacy permittee or pharmacist-in-charge shall:
- 1. Ensure that policies and procedures for the operation and management of the pharmacy’s CQA program are prepared, implemented, and complied with;
- 2. Review biennially and, if necessary, revise the policies and procedures required under subsection (C)(1);
- 3. Document the review required under subsection (C)(2);
- 4. Assemble the policies and procedures as a written or electronic manual; and
- 5. Make the policies and procedures available within the pharmacy for employee reference and inspection by the Board or its staff.
D. The policies and procedures shall address a planned process to:
- 1. Train all pharmacy personnel in relevant phases of the CQA program;
- 2. Identify and document medication errors;
3. Record, measure, and analyze data collected to:
- a. Assess the causes and any contributing factors relating to medication errors, and
- b. Improve the quality of patient care;
- 4. Utilize the findings from subsections (D)(2) and (3) to develop pharmacy systems and workflow processes designed to prevent or reduce medication errors; and
- 5. Communicate periodically, and at least annually, with pharmacy personnel to review CQA program findings and inform pharmacy personnel of any changes made to pharmacy policies, procedures, systems, or processes as a result of CQA program findings.
- E. The Board’s regulatory oversight activities regarding a pharmacy’s CQA program are limited to inspection of the pharmacy’s CQA policies and procedures and enforcing the pharmacy’s compliance with those policies and procedures.
- F. A pharmacy’s compliance with this Section shall be considered by the Board as a mitigating factor in the investigation and evaluation of a medication error.
Historical Note
New Section made by final rulemaking at 18 A.A.R. 2603, effective December 2, 2012 (Supp. 12-4).